Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

Conditions

• Acne Scars - Mixed Atrophic and Hypertrophic
• Hyperpigmentation
• Laser-Induced Hyperpigmentation

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Sciton Halo — DEVICE
  Laser treatment

Study Details

The investigators aim to investigate the efficacy and tolerability of a hybrid non-ablative/ablative laser for acne scarring in skin of color.

Key Dates

Start date

Oct 11, 2023

Status verified

May 2025

Primary completion

Sep 30, 2026

Completion

Sep 30, 2026

Study Design

Enrollment

46 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Hybrid Fractional laser - SOC
  23 participants with fitzpatrick skin type IV-V will be in this arm. At the first visit, participants will undergo informed consent, education about the procedure, education about proper sun-care, and will be provided sunscreen. Participants will be prescribed a prescription of hydroquinone or a retinol to prevent hyperpigmentation, per standard of care. If participants choose to take this they will wait one month of taking the prescription and then begin treatment sessions. If not, participants can begin treatment sessions right away. Treatment consists of 3 laser sessions with the Sciton Halo hybrid fractional laser. Session amount depends on the degree of improvement. At each session before and after images will be collected. At each session participants will fill out the dermatology quality of life survey as well as a patient satisfaction survey.
• Experimental: Hybrid Fractional laser- Non- SOC
  23 participants with Fitzpatrick skin type I-III will be in this arm. At the first visit, participants will undergo informed consent, education about the procedure, education about proper sun-care, and will be provided sunscreen. Participants will be prescribed a prescription of hydroquinone or a retinol to prevent hyperpigmentation, per standard of care. If participants choose to take this they will wait one month of taking the prescription and then begin treatment sessions. If not, participants can begin treatment sessions right away. Treatment consists of 3 laser sessions with the Sciton Halo hybrid fractional laser. Session amount depends on the degree of improvement. At each session before and after images will be collected. At each session participants will fill out the dermatology quality of life survey as well as a patient satisfaction survey.

Primary Outcome Measure

Change from baseline acne scar severity [ Time Frame: month 3 ]

Central Contacts

• Anika Jallorina, BS
  618-704-8716
  [email protected]

Locations (1)

Find similar trials in Elmsford, NY

Related Studies

• AVAVA MIRIA General Use
  Recruiting · AVAVA, Inc. · Waltham, Massachusetts
• An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product
  PHASE3 · Enrolling By Invitation · Good Molecules, LLC · Teaneck, New Jersey